PTGS2 and Alzheimer disease: Notably, an in vitro study revealed that increased concentrations of ceruloplasmin in AD patients can potentiate the proinflammatory activation of microglial cells by upregulating NO release and the mRNA profile of encoding interleukins and enzymes, such as cyclooxygenase-2 (COX-2) or NADPH oxidase [172].